Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1610.15
-29.15 (-1.78%)
< Home < Back

Sun Pharmaceutical recalling two batches of Riomet from US market

Date: 22-12-2017

Sun Pharmaceutical Industries has started recalling two batches of Riomet (metformin hydrochloride) Oral Solution voluntarily from the US market due to microbial contamination. Riomet (metformin oral solution) is an oral diabetes medicine that helps control blood sugar level.

The recall was initiated by the firm under ‘Class-II’ classification. Class II recall is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.